Expect New Cholesterol Injectables to Be Saved as Statin Add-Ons

You'll hear buzz about "PCSK9 inhibitors" for high cholesterol, Praluent (PRAL-you-ent, alirocumab) and Repatha (ree-PATH-ah, evolocumab).

Health Canada will probably consider these for approval within the next year. Praluent has recently been approved in the U.S...and Repatha will soon follow.

These will be the first "biologic" injectable cholesterol meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote